Notogen Inc.
PrivateTotal Funding Raised
$12.5M
Company Overview
Notogen Inc. is a biotechnology company that develops regenerative therapeutics for musculoskeletal conditions, specifically targeting degenerative disc disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
regenerative medicinedegenerative disc diseaseDDDbiologic therapeuticsorthopedic medicinespinal repairback pain treatmentrecombinant proteinsdrug discoverypreclinical biotechbiotech startupnon-surgical spine caretissue regenerationbiotech licensingspine tech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Notogen Inc. Comparables
Compare Notogen Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spine BioPharma, Inc. | 82% | |
| ReGelTec, Inc. | 82% | |
| Stayble Therapeutics AB | 78% | |
Notogen Inc. Funding Rounds
Historical fundraising activity
Notogen Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Notogen Inc.'s valuation, stock price, and market status.